Sunshine Biopharma Inc.
SBFM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001402328
No open-market purchases or sales by Sunshine Biopharma Inc. insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $32.6K in total; no superinvestor holds it.
Other share classesSBFMW
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Sunshine Biopharma Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Sunshine Biopharma Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Natan David | Director | 68,300 | Aug 11, 2026 | 2 |
| Slilaty Steve N. | Chief Executive Officer | 130,000 | Mar 5, 2024 | 0 |
| Sebaaly Camille | CFO/Secretary | 174,465 | Dec 2, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 5, 2024 (view filing)4:05 PM ET | Mar 4 | 1 day | Slilaty Steve N.Chief Executive Officer | PPurchaseSeries B Preferred Stock | +100.0K | $0.10 | +$10.0K | +333.3%130.0K after | |
| Feb 12, 2024 (view filing)4:05 PM ET | Feb 8 | 4 days | Slilaty Steve N.Chief Executive Officer | PPurchaseSeries B Preferred Stock | +20.0K | $0.10 | +$2.00K | +200.0%30.0K after | |
| Dec 2, 2022 (view filing) | Nov 30 | 2 days | Sebaaly CamilleCFO/Secretary | PPurchase | +30.0K | $0.76 | +$22.8K | +20.8%174.5K after | |
| Jun 6, 2022 (view filing) | Jun 3 | 3 days | Sebaaly CamilleCFO/Secretary | PPurchase | +25.0K | $1.22 | +$30.5K | +20.9%144.5K after |